WASHINGTON (AP) — At least one mystery about President Joe Biden’s often convoluted answers during the presidential debate has been solved. Early in the debate, the 81-year-old Democrat was asked a question about the national debt and ended his meandering answer by declaring, “We finally beat Medicare.” That was not what Biden had intended to […]
WASHINGTON — The Supreme Court on Thursday blew up the massive bankruptcy reorganization of opioid maker Purdue Pharma, finding that the settlement inappropriately included legal protections for the Sackler family, meaning that billions of dollars secured for victims is now threatened. The court on a 5-4 vote on nonideological lines ruled that the bankruptcy court did […]
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have shielded its wealthy Sackler family owners from lawsuits over their role in the nation’s deadly opioid epidemic. The 5-4 decision reversed a lower court’s ruling that had upheld the plan to give Purdue’s […]
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have shielded its wealthy Sackler family owners from lawsuits over their role in the nation’s deadly opioid epidemic. The 5-4 decision reversed a lower court’s ruling that had upheld the plan to give Purdue’s […]
The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic. After deliberating more than six months, the […]
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have shielded its wealthy Sackler family owners from lawsuits over their role in the nation’s deadly opioid epidemic. The 5-4 decision reversed a lower court’s ruling that had upheld the plan to give Purdue’s […]
EXCLUSIVE: ‘Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,’ Petros Pharma President Says Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of Petros Pharmaceuticals, said the company aims to expand access of […]
Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) — and it isn’t even close. Lilly continues to widen its lead over all other healthcare companies. It just reached yet another […]
Most Americans loathe their health insurance providers. A majority say they have severe concerns about financial hardship due to medical bills—even with insurance coverage—thanks to denied claims, unexpected charges, and a refusal to pay for out-of-network doctor visits. And, according to one poll, nearly half of insured adults say they were unable to solve their […]
(Bloomberg) — European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc. Most Read from Bloomberg The analysts initiated coverage of six large-cap pharmaceutical stocks on Thursday, saying “innovation is the key to success.” They gave buy ratings to AstraZeneca Plc, Novo Nordisk […]
A sum of $500 might not seem like much of an investment, but if you select the right pharmaceutical stocks — and are patient enough to hold them forever — history shows you’ll have a very high chance of ending up with many times more money than at the start. With that in mind, let’s […]
Pfizer (PFE) stock jumped early Wednesday after the Big Pharma behemoth reported adjusted earnings of 82 cents per share on $14.88 billion in first-quarter sales. X On average, analysts polled by FactSet expected Pfizer to earn an adjusted 51 cents per share on $13.87 billion in sales. In the year-earlier period, Pfizer earnings were $1.23 […]